Plasma homocysteine, folate and B12 in chronic schizophrenia
Authors:
- Alexandros HaidemenosAHAlexandros Haidemenos
- Dimitrios KontisDKDimitrios Kontis
- Anthia GaziAGAnthia Gazi
- Eleni KallaiEKEleni Kallai
- Boniatsi LuciaBLBoniatsi Lucia
- 1 August 2007
- journal article
- review article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 31 (6) , 1289-1296
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Elevated Prenatal Homocysteine Levels as a Risk Factor for SchizophreniaArchives of General Psychiatry, 2007
- Homocysteine levels in adolescent schizophrenia patientsEuropean Neuropsychopharmacology, 2006
- Folate, Homocysteine, and Negative Symptoms in SchizophreniaAmerican Journal of Psychiatry, 2004
- Homocysteine levels in newly admitted schizophrenic patientsJournal of Psychiatric Research, 2004
- The associations between smoking, physical activity, dietary habits and plasma homocysteine levels in cardiovascular disease-free people: the ‘ATTICA’ studyVascular Medicine, 2004
- Multiple aspects of homocysteine neurotoxicity: Glutamate excitotoxicity, kinase hyperactivation and DNA damageJournal of Neuroscience Research, 2002
- The Emerging Role of Glutamate in the Pathophysiology and Treatment of SchizophreniaAmerican Journal of Psychiatry, 2001
- Folate levels in psychiatric outpatientsPsychiatry and Clinical Neurosciences, 1999
- Common Methylenetetrahydrofolate Reductase Gene Mutation Leads to Hyperhomocysteinemia but Not to Vascular DiseaseCirculation, 1998
- Methylenetetrahydrofolate reductase variant and schizophrenia/depressionAmerican Journal of Medical Genetics, 1997